These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1939566)

  • 1. Highly diverse dynamics of Pseudomonas aeruginosa colonization from initial detection in cystic fibrosis patients: A 7-year longitudinal genetic diversity study.
    Dupont C; Aujoulat F; Benaoudia M; Jumas-Bilak E; Chiron R; Marchandin H
    Infect Genet Evol; 2023 Nov; 115():105513. PubMed ID: 37832753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular
    Crabbé A
    Am J Respir Crit Care Med; 2024 Jun; 209(12):1421-1423. PubMed ID: 38498854
    [No Abstract]   [Full Text] [Related]  

  • 3. Simple and inexpensive but highly discriminating method for computer-assisted DNA fingerprinting of Pseudomonas aeruginosa.
    Al-Samarrai TH; Zhang N; Lamont IL; Martin L; Kolbe J; Wilsher M; Morris AJ; Schmid J
    J Clin Microbiol; 2000 Dec; 38(12):4445-52. PubMed ID: 11101578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriocin-mediated competition in cystic fibrosis lung infections.
    Ghoul M; West SA; Johansen HK; Molin S; Harrison OB; Maiden MC; Jelsbak L; Bruce JB; Griffin AS
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26311664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.
    Delhaes L; Monchy S; Fréalle E; Hubans C; Salleron J; Leroy S; Prevotat A; Wallet F; Wallaert B; Dei-Cas E; Sime-Ngando T; Chabé M; Viscogliosi E
    PLoS One; 2012; 7(4):e36313. PubMed ID: 22558432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the microbiota of the cystic fibrosis lung and human gut.
    Rogers GB; Carroll MP; Hoffman LR; Walker AW; Fine DA; Bruce KD
    Gut Microbes; 2010 Mar; 1(2):85-93. PubMed ID: 21326915
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-sectional and longitudinal multilocus sequence typing of pseudomonas aeruginosa in cystic fibrosis sputum samples.
    Waine DJ; Honeybourne D; Smith EG; Whitehouse JL; Dowson CG
    J Clin Microbiol; 2009 Nov; 47(11):3444-8. PubMed ID: 19710263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.
    Mahenthiralingam E; Campbell ME; Foster J; Lam JS; Speert DP
    J Clin Microbiol; 1996 May; 34(5):1129-35. PubMed ID: 8727889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction endonuclease analysis of clinical Pseudomonas aeruginosa strains: useful epidemiologic data from a simple and rapid method.
    Maher WE; Kobe M; Fass RJ
    J Clin Microbiol; 1993 Jun; 31(6):1426-9. PubMed ID: 8391021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribotyping of Pseudomonas aeruginosa: discriminatory power and usefulness as a tool for epidemiological studies.
    Blanc DS; Siegrist HH; Sahli R; Francioli P
    J Clin Microbiol; 1993 Jan; 31(1):71-7. PubMed ID: 8093252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between transcript levels of the Pseudomonas aeruginosa regA, regB, and toxA genes in sputa of cystic fibrosis patients.
    Raivio TL; Ujack EE; Rabin HR; Storey DG
    Infect Immun; 1994 Aug; 62(8):3506-14. PubMed ID: 8039921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region.
    Martin C; Ichou MA; Massicot P; Goudeau A; Quentin R
    J Clin Microbiol; 1995 Jun; 33(6):1461-6. PubMed ID: 7544364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Wolz C; Döring G; Lam JS; Rosdahl VT; Høiby N
    APMIS; 1990 May; 98(5):423-31. PubMed ID: 2113398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Spencker FB; Haupt S; Claros MC; Walter S; Lietz T; Schille R; Rodloff AC
    Clin Microbiol Infect; 2000 Nov; 6(11):600-7. PubMed ID: 11168063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Römling U; Fiedler B; Bosshammer J; Grothues D; Greipel J; von der Hardt H; Tümmler B
    J Infect Dis; 1994 Dec; 170(6):1616-21. PubMed ID: 7996008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients.
    Fegan M; Francis P; Hayward AC; Fuerst JA
    J Clin Microbiol; 1991 Oct; 29(10):2151-7. PubMed ID: 1939566
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.